These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9684912)
41. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro. Hammarén E; Rosenberg PH; Hynynen M Br J Anaesth; 1999 Jan; 82(1):38-40. PubMed ID: 10325833 [TBL] [Abstract][Full Text] [Related]
42. Extracorporeal membrane oxygenation without anticoagulation: a study using quantitative scanning electron microscopy. Kundu SK; Salley SO; Whittlesey GC; Klein MD J Lab Clin Med; 1989 Jul; 114(1):58-62. PubMed ID: 2738449 [TBL] [Abstract][Full Text] [Related]
44. Use of A heparin-coated circuit for extracorporeal circulation with selective cerebral perfusion. Hattori K; Suehiro S; Shibata T; Sasaki Y; Kumano H; Kinoshita H Osaka City Med J; 2000 Dec; 46(2):111-8. PubMed ID: 11252730 [TBL] [Abstract][Full Text] [Related]
45. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305 [TBL] [Abstract][Full Text] [Related]
46. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS. Bindslev L; Böhm C; Jolin A; Hambraeus Jonzon K; Olsson P; Ryniak S Acta Anaesthesiol Scand Suppl; 1991; 95():125-30; discussion 130-1. PubMed ID: 1927222 [TBL] [Abstract][Full Text] [Related]
47. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits]. Yoshie M; Hirose Y; Gamo M; Matsuo K Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775 [TBL] [Abstract][Full Text] [Related]
48. Twenty-four-hour venoarterial extracorporeal membrane oxygenation without systemic heparinization in dogs. Miyasaka K; Takata M; Muto R Pediatr Surg Int; 1996 Aug; 11(7):466-70. PubMed ID: 24057784 [TBL] [Abstract][Full Text] [Related]
49. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation. Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857 [TBL] [Abstract][Full Text] [Related]
50. Objective assessment of heparin requirements for hemodialysis in humans. Ireland H; Lane DA; Curtis JR J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409 [TBL] [Abstract][Full Text] [Related]
51. Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Yu K; Long C; Hei F; Li J; Liu J; Ji B; Gao G; Zhang H; Song Y; Wang W Artif Organs; 2011 Jul; 35(7):733-7. PubMed ID: 21375546 [TBL] [Abstract][Full Text] [Related]
52. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces. Kirschfink M; Kovacs B; Mottaghy K Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684 [TBL] [Abstract][Full Text] [Related]
53. Inactivation of heparin during extracorporeal circulation in infants. Green TP; Isham-Schopf B; Irmiter RJ; Smith C; Uden DL; Steinhorn RH Clin Pharmacol Ther; 1990 Aug; 48(2):148-54. PubMed ID: 2379386 [TBL] [Abstract][Full Text] [Related]